KALV
Kalvista Pharmaceuticals Inc
NASDAQ: KALV · HEALTHCARE · BIOTECHNOLOGY
$27.00
+0.00% today
Updated 2026-06-12
Market cap
$1.44B
P/E ratio
—
P/S ratio
12.55x
EPS (TTM)
$-3.94
Dividend yield
—
52W range
$10 – $27
Volume
4.2M
Kalvista Pharmaceuticals Inc (KALV) Insider transactions
Net insider activity
Net buying (652,774 shares)
Buy transactions
40
Sell transactions
60
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-26 | VENROCK, HEALTHCARE CAPITAL PARTNERS III, L.P. | 10% Owner | Sale | 21,386 | $17.76 | $379815.36 |
| 2026-03-26 | VENROCK, HEALTHCARE CAPITAL PARTNERS III, L.P. | 10% Owner | Sale | 15,417 | $18.82 | $290147.94 |
| 2026-03-26 | VENROCK, HEALTHCARE CAPITAL PARTNERS III, L.P. | 10% Owner | Sale | 3,183 | $19.12 | $60858.96 |
| 2026-03-25 | VENROCK, HEALTHCARE CAPITAL PARTNERS III, L.P. | 10% Owner | Sale | 174,485 | $16.95 | $2.96M |
| 2026-03-25 | VENROCK, HEALTHCARE CAPITAL PARTNERS III, L.P. | 10% Owner | Sale | 160 | $17.53 | $2804.80 |
| 2026-03-09 | PALLEIKO, BENJAMIN L | Director, CHIEF EXECUTIVE OFFICER | Sale | 6,693 | $16.08 | $107632.81 |
| 2026-03-06 | PALLEIKO, BENJAMIN L | Director, CHIEF EXECUTIVE OFFICER | Sale | 15,625 | — | — |
| 2026-03-06 | PALLEIKO, BENJAMIN L | Director, CHIEF EXECUTIVE OFFICER | Buy | 15,625 | — | — |
| 2026-02-23 | YEA, CHRISTOPHER | CHIEF DEVELOPMENT OFFICER | Sale | 4,347 | $15.57 | $67668.88 |
| 2026-02-23 | SWEENY, NICOLE | Chief Commercial Officer | Sale | 3,975 | $15.57 | $61878.03 |
| 2026-02-23 | PIEKOS, BRIAN | Chief Financial Officer | Sale | 1,767 | $15.57 | $27506.54 |
| 2026-02-23 | PALLEIKO, BENJAMIN L | Director, CHIEF EXECUTIVE OFFICER | Sale | 10,034 | $15.57 | $156197.27 |
| 2026-02-23 | AUDHYA, PAUL K. | CHIEF MEDICAL OFFICER | Sale | 5,354 | $15.57 | $83344.65 |
| 2026-02-22 | YEA, CHRISTOPHER | CHIEF DEVELOPMENT OFFICER | Sale | 3,125 | — | — |
| 2026-02-22 | YEA, CHRISTOPHER | CHIEF DEVELOPMENT OFFICER | Buy | 3,125 | — | — |
| 2026-02-22 | SWEENY, NICOLE | Chief Commercial Officer | Sale | 5,000 | — | — |
| 2026-02-22 | SWEENY, NICOLE | Chief Commercial Officer | Buy | 5,000 | — | — |
| 2026-02-22 | AUDHYA, PAUL K. | CHIEF MEDICAL OFFICER | Sale | 5,000 | — | — |
| 2026-02-22 | AUDHYA, PAUL K. | CHIEF MEDICAL OFFICER | Buy | 5,000 | — | — |
| 2026-02-21 | YEA, CHRISTOPHER | CHIEF DEVELOPMENT OFFICER | Sale | 3,750 | — | — |
| 2026-02-21 | YEA, CHRISTOPHER | CHIEF DEVELOPMENT OFFICER | Buy | 3,750 | — | — |
| 2026-02-21 | SWEENY, NICOLE | Chief Commercial Officer | Sale | 6,250 | — | — |
| 2026-02-21 | SWEENY, NICOLE | Chief Commercial Officer | Buy | 6,250 | — | — |
| 2026-02-21 | PIEKOS, BRIAN | Chief Financial Officer | Sale | 5,000 | — | — |
| 2026-02-21 | PIEKOS, BRIAN | Chief Financial Officer | Buy | 5,000 | — | — |
| 2026-02-21 | PALLEIKO, BENJAMIN L | Director, CHIEF EXECUTIVE OFFICER | Sale | 23,250 | — | — |
| 2026-02-21 | PALLEIKO, BENJAMIN L | Director, CHIEF EXECUTIVE OFFICER | Buy | 23,250 | — | — |
| 2026-02-21 | AUDHYA, PAUL K. | CHIEF MEDICAL OFFICER | Sale | 6,250 | — | — |
| 2026-02-21 | AUDHYA, PAUL K. | CHIEF MEDICAL OFFICER | Buy | 6,250 | — | — |
| 2026-02-18 | YEA, CHRISTOPHER | CHIEF DEVELOPMENT OFFICER | Sale | 1,109 | $15.00 | $16635.00 |
| 2026-02-18 | PALLEIKO, BENJAMIN L | Director, CHIEF EXECUTIVE OFFICER | Sale | 1,038 | $15.00 | $15570.00 |
| 2026-02-18 | AUDHYA, PAUL K. | CHIEF MEDICAL OFFICER | Sale | 1,163 | $15.00 | $17445.00 |
| 2026-02-17 | YEA, CHRISTOPHER | CHIEF DEVELOPMENT OFFICER | Sale | 1,774 | — | — |
| 2026-02-17 | YEA, CHRISTOPHER | CHIEF DEVELOPMENT OFFICER | Buy | 1,774 | — | — |
| 2026-02-17 | PALLEIKO, BENJAMIN L | Director, CHIEF EXECUTIVE OFFICER | Sale | 2,419 | — | — |
| 2026-02-17 | PALLEIKO, BENJAMIN L | Director, CHIEF EXECUTIVE OFFICER | Buy | 2,419 | — | — |
| 2026-02-17 | AUDHYA, PAUL K. | CHIEF MEDICAL OFFICER | Sale | 2,419 | — | — |
| 2026-02-17 | AUDHYA, PAUL K. | CHIEF MEDICAL OFFICER | Buy | 2,419 | — | — |
| 2026-02-12 | PALLEIKO, BENJAMIN L | Director, CHIEF EXECUTIVE OFFICER | Sale | 3,354 | $15.70 | $52657.80 |
| 2026-02-11 | PALLEIKO, BENJAMIN L | Director, CHIEF EXECUTIVE OFFICER | Sale | 7,120 | — | — |
| 2026-02-11 | PALLEIKO, BENJAMIN L | Director, CHIEF EXECUTIVE OFFICER | Buy | 7,120 | — | — |
| 2026-01-16 | SWEENY, NICOLE | Chief Commercial Officer | Buy | 100,000 | — | — |
| 2026-01-16 | PIEKOS, BRIAN | Chief Financial Officer | Buy | 100,000 | — | — |
| 2026-01-16 | PALLEIKO, BENJAMIN L | Director, CHIEF EXECUTIVE OFFICER | Buy | 325,000 | — | — |
| 2026-01-16 | AUDHYA, PAUL K. | CHIEF MEDICAL OFFICER | Buy | 100,000 | — | — |
| 2026-01-16 | ARIF, BILAL | Chief Operations Officer | Buy | 49,000 | — | — |
| 2025-12-08 | PALLEIKO, BENJAMIN L | Director, CHIEF EXECUTIVE OFFICER | Sale | 7,294 | $16.51 | $120423.94 |
| 2025-12-06 | PALLEIKO, BENJAMIN L | Director, CHIEF EXECUTIVE OFFICER | Sale | 15,625 | — | — |
| 2025-12-06 | PALLEIKO, BENJAMIN L | Director, CHIEF EXECUTIVE OFFICER | Buy | 15,625 | — | — |
| 2025-11-24 | YEA, CHRISTOPHER | CHIEF DEVELOPMENT OFFICER | Sale | 4,331 | $13.45 | $58256.28 |
| 2025-11-24 | SWEENY, NICOLE | Chief Commercial Officer | Sale | 3,813 | $13.45 | $51288.66 |
| 2025-11-24 | PIEKOS, BRIAN | Chief Financial Officer | Sale | 4,471 | $13.45 | $60139.42 |
| 2025-11-24 | PALLEIKO, BENJAMIN L | Director, CHIEF EXECUTIVE OFFICER | Sale | 10,940 | $13.45 | $147153.94 |
| 2025-11-24 | AUDHYA, PAUL K. | CHIEF MEDICAL OFFICER | Sale | 5,296 | $13.45 | $71236.50 |
| 2025-11-22 | YEA, CHRISTOPHER | CHIEF DEVELOPMENT OFFICER | Sale | 3,125 | — | — |
| 2025-11-22 | YEA, CHRISTOPHER | CHIEF DEVELOPMENT OFFICER | Buy | 3,125 | — | — |
| 2025-11-22 | SWEENY, NICOLE | Chief Commercial Officer | Sale | 5,000 | — | — |
| 2025-11-22 | SWEENY, NICOLE | Chief Commercial Officer | Buy | 5,000 | — | — |
| 2025-11-22 | AUDHYA, PAUL K. | CHIEF MEDICAL OFFICER | Sale | 5,000 | — | — |
| 2025-11-22 | AUDHYA, PAUL K. | CHIEF MEDICAL OFFICER | Buy | 5,000 | — | — |
| 2025-11-21 | YEA, CHRISTOPHER | CHIEF DEVELOPMENT OFFICER | Sale | 3,750 | — | — |
| 2025-11-21 | YEA, CHRISTOPHER | CHIEF DEVELOPMENT OFFICER | Buy | 3,750 | — | — |
| 2025-11-21 | SWEENY, NICOLE | Chief Commercial Officer | Sale | 6,250 | — | — |
| 2025-11-21 | SWEENY, NICOLE | Chief Commercial Officer | Buy | 6,250 | — | — |
| 2025-11-21 | PIEKOS, BRIAN | Chief Financial Officer | Sale | 15,000 | — | — |
| 2025-11-21 | PIEKOS, BRIAN | Chief Financial Officer | Buy | 15,000 | — | — |
| 2025-11-21 | PALLEIKO, BENJAMIN L | Director, CHIEF EXECUTIVE OFFICER | Sale | 23,250 | — | — |
| 2025-11-21 | PALLEIKO, BENJAMIN L | Director, CHIEF EXECUTIVE OFFICER | Buy | 23,250 | — | — |
| 2025-11-21 | AUDHYA, PAUL K. | CHIEF MEDICAL OFFICER | Sale | 6,250 | — | — |
| 2025-11-21 | AUDHYA, PAUL K. | CHIEF MEDICAL OFFICER | Buy | 6,250 | — | — |
| 2025-11-20 | YEA, CHRISTOPHER | CHIEF DEVELOPMENT OFFICER | Sale | 87,390 | — | — |
| 2025-11-20 | YEA, CHRISTOPHER | CHIEF DEVELOPMENT OFFICER | Buy | 87,390 | $0.00 | $375.78 |
| 2025-11-18 | YEA, CHRISTOPHER | CHIEF DEVELOPMENT OFFICER | Sale | 2,683 | $14.48 | $38848.23 |
| 2025-11-18 | PALLEIKO, BENJAMIN L | Director, CHIEF EXECUTIVE OFFICER | Sale | 4,466 | $14.48 | $64665.00 |
| 2025-11-18 | AUDHYA, PAUL K. | CHIEF MEDICAL OFFICER | Sale | 3,075 | $14.48 | $44524.46 |
| 2025-11-17 | YEA, CHRISTOPHER | CHIEF DEVELOPMENT OFFICER | Sale | 2,431 | — | — |
| 2025-11-17 | YEA, CHRISTOPHER | CHIEF DEVELOPMENT OFFICER | Sale | 1,774 | — | — |
| 2025-11-17 | YEA, CHRISTOPHER | CHIEF DEVELOPMENT OFFICER | Buy | 4,205 | — | — |
| 2025-11-17 | PALLEIKO, BENJAMIN L | Director, CHIEF EXECUTIVE OFFICER | Sale | 6,945 | — | — |
| 2025-11-17 | PALLEIKO, BENJAMIN L | Director, CHIEF EXECUTIVE OFFICER | Sale | 2,419 | — | — |
| 2025-11-17 | PALLEIKO, BENJAMIN L | Director, CHIEF EXECUTIVE OFFICER | Buy | 9,364 | — | — |
| 2025-11-17 | AUDHYA, PAUL K. | CHIEF MEDICAL OFFICER | Sale | 4,028 | — | — |
| 2025-11-17 | AUDHYA, PAUL K. | CHIEF MEDICAL OFFICER | Sale | 2,419 | — | — |
| 2025-11-17 | AUDHYA, PAUL K. | CHIEF MEDICAL OFFICER | Buy | 6,447 | — | — |
| 2025-11-12 | PALLEIKO, BENJAMIN L | Director, CHIEF EXECUTIVE OFFICER | Sale | 3,328 | $11.55 | $38438.40 |
| 2025-11-11 | PALLEIKO, BENJAMIN L | Director, CHIEF EXECUTIVE OFFICER | Sale | 7,120 | — | — |
| 2025-11-11 | PALLEIKO, BENJAMIN L | Director, CHIEF EXECUTIVE OFFICER | Buy | 7,120 | — | — |
| 2025-10-08 | ARIF, BILAL | Chief Operations Officer | Buy | 100,000 | — | — |
| 2025-10-01 | UNKART, EDWARD W | Director | Buy | 30,000 | — | — |
| 2025-10-01 | TREANOR, PATRICK | Director | Buy | 30,000 | — | — |
| 2025-10-01 | STUART, NANCY | Director | Buy | 30,000 | — | — |
| 2025-10-01 | SENSENIG, BETHANY | Director | Buy | 45,000 | — | — |
| 2025-10-01 | PEREIRA, BRIAN JG | Director | Buy | 30,000 | — | — |
| 2025-10-01 | FAIREY, WILLIAM | Director | Buy | 30,000 | — | — |
| 2025-09-08 | PALLEIKO, BENJAMIN L | Director, CHIEF EXECUTIVE OFFICER | Sale | 7,294 | $15.84 | $115536.96 |
| 2025-09-06 | PALLEIKO, BENJAMIN L | Director, CHIEF EXECUTIVE OFFICER | Sale | 15,625 | — | — |
| 2025-09-06 | PALLEIKO, BENJAMIN L | Director, CHIEF EXECUTIVE OFFICER | Buy | 15,625 | — | — |
| 2025-08-25 | YEA, CHRISTOPHER | CHIEF DEVELOPMENT OFFICER | Sale | 1,954 | $13.42 | $26222.68 |
| 2025-08-25 | SWEENY, NICOLE | Chief Commercial Officer | Sale | 1,480 | $13.42 | $19861.60 |
| 2025-08-25 | AUDHYA, PAUL K. | CHIEF MEDICAL OFFICER | Sale | 2,336 | $13.42 | $31349.12 |
Frequently asked questions
Are KALV insiders buying or selling?
Over the transactions on record, KALV insiders have been net sellers, with about $5.19M in stock sold across 60 sales, against 1 open-market purchase.
Does insider selling at KALV mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which KALV insiders are selling the most?
Recent selling is concentrated in a few names. VENROCK, HEALTHCARE CAPITAL PARTNERS III, L.P. accounts for the largest share on record, with about $3.69M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.